Compass Therapeutics annual meeting elects three directors, ratifies auditor

Compass Therapeutics, Inc.

Carl L. Gordon, Philip J. Ferneau, and James P. Boylan elected as Class II directors with 80.7M, 58.3M, and 83.6M votes for, respectively.
Ratification of CohnReznick LLP as auditor for FY2025 approved with 114.3M for, 28,647 against, 22,788 abstain.
Broker non-votes of 29,432,541 on director election.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.